Specialty Business Services
Compare Stocks
4 / 10Stock Comparison
SGRP vs KELYA vs MAN vs TBI
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
Staffing & Employment Services
Staffing & Employment Services
SGRP vs KELYA vs MAN vs TBI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Business Services | Staffing & Employment Services | Staffing & Employment Services | Staffing & Employment Services |
| Market Cap | $16M | $349M | $1.41B | $182M |
| Revenue (TTM) | $147M | $3.09B | $17.96B | $1.25B |
| Net Income (TTM) | $-22M | $-266M | $-13M | $-53M |
| Gross Margin | 20.7% | 26.3% | 16.7% | 28.4% |
| Operating Margin | -11.7% | -2.8% | 0.8% | -2.6% |
| Forward P/E | — | 11.0x | 8.3x | — |
| Total Debt | $19M | $159M | $2.39B | $171M |
| Cash & Equiv. | $18M | $33M | $871M | $25M |
SGRP vs KELYA vs MAN vs TBI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SPAR Group, Inc. (SGRP) | 100 | 99.0 | -1.0% |
| Kelly Services, Inc. (KELYA) | 100 | 64.7 | -35.3% |
| ManpowerGroup Inc. (MAN) | 100 | 44.0 | -56.0% |
| TrueBlue, Inc. (TBI) | 100 | 38.9 | -61.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SGRP vs KELYA vs MAN vs TBI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SGRP is the clearest fit if your priority is long-term compounding.
- -28.9% 10Y total return vs KELYA's -33.0%
- Beta 0.05 vs TBI's 1.13
KELYA is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.01, Low D/E 16.3%, current ratio 1.54x
- Beta 1.01, yield 3.2%, current ratio 1.54x
- 3.2% yield, 5-year raise streak, vs MAN's 4.7%, (2 stocks pay no dividend)
MAN carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 0 yrs, beta 1.03, yield 4.7%
- Better valuation composite
- -0.1% margin vs SGRP's -14.7%
- -0.1% ROA vs SGRP's -35.0%, ROIC 5.6% vs -1.8%
TBI is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 3.1%, EPS growth 61.4%, 3Y rev CAGR -10.5%
- 3.1% revenue growth vs SGRP's -5.5%
- +51.0% vs SGRP's -34.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.1% revenue growth vs SGRP's -5.5% | |
| Value | Better valuation composite | |
| Quality / Margins | -0.1% margin vs SGRP's -14.7% | |
| Stability / Safety | Beta 0.05 vs TBI's 1.13 | |
| Dividends | 3.2% yield, 5-year raise streak, vs MAN's 4.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +51.0% vs SGRP's -34.4% | |
| Efficiency (ROA) | -0.1% ROA vs SGRP's -35.0%, ROIC 5.6% vs -1.8% |
SGRP vs KELYA vs MAN vs TBI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SGRP vs KELYA vs MAN vs TBI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MAN leads in 3 of 6 categories
SGRP leads 1 • KELYA leads 0 • TBI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MAN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 122.1x SGRP's $147M. MAN is the more profitable business, keeping -0.1% of every revenue dollar as net income compared to SGRP's -14.7%. On growth, SGRP holds the edge at +9.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $147M | $3.1B | $18.0B | $1.2B |
| EBITDAEarnings before interest/tax | -$16M | -$54M | $236M | -$10M |
| Net IncomeAfter-tax profit | -$22M | -$266M | -$13M | -$53M |
| Free Cash FlowCash after capex | -$18M | $66M | -$161M | -$60M |
| Gross MarginGross profit ÷ Revenue | +20.7% | +26.3% | +16.7% | +28.4% |
| Operating MarginEBIT ÷ Revenue | -11.7% | -2.8% | +0.8% | -2.6% |
| Net MarginNet income ÷ Revenue | -14.7% | -8.6% | -0.1% | -4.3% |
| FCF MarginFCF ÷ Revenue | -12.0% | +2.1% | -0.9% | -4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | -100.0% | +7.1% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -2.1% | +36.2% | -37.5% |
Valuation Metrics
MAN leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, MAN's 9.0x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $16M | $349M | $1.4B | $182M |
| Enterprise ValueMkt cap + debt − cash | $17M | $475M | $2.9B | $329M |
| Trailing P/EPrice ÷ TTM EPS | -5.25x | -1.34x | -104.90x | -3.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.96x | 8.28x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 14.97x | — | 9.02x | 160.03x |
| Price / SalesMarket cap ÷ Revenue | 0.37x | 0.08x | 0.08x | 0.11x |
| Price / BookPrice ÷ Book value/share | 0.67x | 0.35x | 0.69x | 0.65x |
| Price / FCFMarket cap ÷ FCF | — | 3.06x | — | — |
Profitability & Efficiency
MAN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MAN delivers a -0.6% return on equity — every $100 of shareholder capital generates $-1 in annual profit, vs $-130 for SGRP. KELYA carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAN's 1.16x. On the Piotroski fundamental quality scale (0–9), KELYA scores 5/9 vs MAN's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -130.0% | -24.6% | -0.6% | -18.7% |
| ROA (TTM)Return on assets | -35.0% | -11.3% | -0.1% | -8.1% |
| ROICReturn on invested capital | -1.8% | -4.0% | +5.6% | -5.2% |
| ROCEReturn on capital employed | -2.8% | -4.3% | +6.2% | -5.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 1 | 4 |
| Debt / EquityFinancial leverage | 0.78x | 0.16x | 1.16x | 0.62x |
| Net DebtTotal debt minus cash | $712,000 | $126M | $1.5B | $146M |
| Cash & Equiv.Liquid assets | $18M | $33M | $871M | $25M |
| Total DebtShort + long-term debt | $19M | $159M | $2.4B | $171M |
| Interest CoverageEBIT ÷ Interest expense | -7.80x | -12.07x | 1.98x | -46.19x |
Total Returns (Dividends Reinvested)
SGRP leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KELYA five years ago would be worth $4,168 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, TBI leads with a +51.0% total return vs SGRP's -34.4%. The 3-year compound annual growth rate (CAGR) favors SGRP at -12.2% vs TBI's -26.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -23.3% | +13.1% | +1.2% | +36.6% |
| 1-Year ReturnPast 12 months | -34.4% | -12.2% | -17.0% | +51.0% |
| 3-Year ReturnCumulative with dividends | -32.4% | -34.2% | -46.4% | -60.2% |
| 5-Year ReturnCumulative with dividends | -58.9% | -58.3% | -64.9% | -78.7% |
| 10-Year ReturnCumulative with dividends | -28.9% | -33.0% | -30.8% | -68.4% |
| CAGR (3Y)Annualised 3-year return | -12.2% | -13.0% | -18.8% | -26.4% |
Risk & Volatility
Evenly matched — SGRP and TBI each lead in 1 of 2 comparable metrics.
Risk & Volatility
SGRP is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TBI currently trades 77.2% from its 52-week high vs SGRP's 48.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 1.01x | 1.03x | 1.13x |
| 52-Week HighHighest price in past year | $1.41 | $14.94 | $47.34 | $7.78 |
| 52-Week LowLowest price in past year | $0.50 | $7.98 | $25.15 | $3.18 |
| % of 52W HighCurrent price vs 52-week peak | +48.4% | +64.9% | +64.3% | +77.2% |
| RSI (14)Momentum oscillator 0–100 | 63.6 | 63.7 | 47.1 | 83.2 |
| Avg Volume (50D)Average daily shares traded | 55K | 361K | 1.1M | 386K |
Analyst Outlook
Evenly matched — KELYA and MAN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KELYA as "Buy", MAN as "Hold", TBI as "Buy". Consensus price targets imply 54.6% upside for KELYA (target: $15) vs -4.3% for TBI (target: $6). For income investors, MAN offers the higher dividend yield at 4.71% vs KELYA's 3.23%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $15.00 | $37.86 | $5.75 |
| # AnalystsCovering analysts | — | 5 | 29 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +3.2% | +4.7% | — |
| Dividend StreakConsecutive years of raises | — | 5 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $0.31 | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +11.1% | +3.5% | +2.7% | +0.6% |
MAN leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). SGRP leads in 1 (Total Returns). 2 tied.
SGRP vs KELYA vs MAN vs TBI: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is SGRP or KELYA or MAN or TBI a better buy right now?
For growth investors, TrueBlue, Inc.
(TBI) is the stronger pick with 3. 1% revenue growth year-over-year, versus -5. 5% for SPAR Group, Inc. (SGRP). Analysts rate Kelly Services, Inc. (KELYA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SGRP or KELYA or MAN or TBI?
Over the past 5 years, Kelly Services, Inc.
(KELYA) delivered a total return of -58. 3%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: SGRP returned -28. 9% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SGRP or KELYA or MAN or TBI?
By beta (market sensitivity over 5 years), SPAR Group, Inc.
(SGRP) is the lower-risk stock at 0. 05β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 2056% more volatile than SGRP relative to the S&P 500. On balance sheet safety, Kelly Services, Inc. (KELYA) carries a lower debt/equity ratio of 16% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — SGRP or KELYA or MAN or TBI?
By revenue growth (latest reported year), TrueBlue, Inc.
(TBI) is pulling ahead at 3. 1% versus -5. 5% for SPAR Group, Inc. (SGRP). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, MAN leads at -3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SGRP or KELYA or MAN or TBI?
ManpowerGroup Inc.
(MAN) is the more profitable company, earning -0. 1% net margin versus -9. 0% for SPAR Group, Inc. — meaning it keeps -0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAN leads at 1. 3% versus -2. 2% for SGRP. At the gross margin level — before operating expenses — TBI leads at 21. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SGRP or KELYA or MAN or TBI more undervalued right now?
On forward earnings alone, ManpowerGroup Inc.
(MAN) trades at 8. 3x forward P/E versus 11. 0x for Kelly Services, Inc. — 2. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 54. 6% to $15. 00.
07Which pays a better dividend — SGRP or KELYA or MAN or TBI?
In this comparison, MAN (4.
7% yield), KELYA (3. 2% yield) pay a dividend. SGRP, TBI do not pay a meaningful dividend and should not be held primarily for income.
08Is SGRP or KELYA or MAN or TBI better for a retirement portfolio?
For long-horizon retirement investors, SPAR Group, Inc.
(SGRP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05)). Both have compounded well over 10 years (SGRP: -28. 9%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SGRP and KELYA and MAN and TBI?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SGRP is a small-cap quality compounder stock; KELYA is a small-cap income-oriented stock; MAN is a small-cap income-oriented stock; TBI is a small-cap quality compounder stock. KELYA, MAN pay a dividend while SGRP, TBI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.